microdosing glp 1 perimenopause GLP-1s are generating a lot of buzz, but most people are only familiar with them as a tool for weight loss., In this episode, @mccallmcphersonpa and I dive deeper to share how these peptides can do so Before you keep scrolling, here’s

While human clinical results are still emerging, the research suggests these drugs could serve as a powerful preventative tool against dementia

Identifying GLP-1 Non-Responders Early in Treatment Early identification of patients who may not respond adequately to GLP-1 receptor agonist therapy represents a critical step in optimizing obesity treatment pathways

Purpose-built for physicians GLP-1 receptor agonist use for more than 1 year may increase thyroid cancer risk Adults with type 2 diabetes who use a GLP-1 receptor agonist for more than 1 year may have an increased risk for thyroid cancer, according to findings published in Diabetes Care

Youve probably seen ads for this all over your TV screens

Tolerability: Tolerability: While the side effect profile of incretin mimetics is relatively mild (low rates of severe AEs